Trial intelligence / Profile preview

Pioglitazone vs Ramipril for Inflammation in Hypertension

NCT00770497Phase 2Completed

Sponsor
Takeda
Start
Mar 2007
Primary completion
May 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pioglitazone in inflammation, sponsored by Takeda. Started Mar 2007; status: completed.

02

Drugs

pioglitazone
03

Conditions

inflammation

Beyond the preview

Go deeper on NCT00770497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00770497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call